This presentation reviews critical elements of diagnosis, important considerations in pharmacotherapy, and utilizes a case study approach to analyze the best treatment regimens. | 1.50 credits (1.50 pharmacology) | $45

This presentation reviews the pathophysiology of ADD as the target of pharmacotherapy. Pharmacotherapeutics of psychostimulants, norepinephrine reuptake inhibitors, antiadrenergic agonists, and wakefulness agents are analyzed, with emphasis on indications and efficacies for each. Case studies are then used to evaluate best-practice options in a variety of clinical scenarios including pediatric, adult and psychostimulants contraindicated. | 1.50 credits (1.50 pharmacology) | $45.00

The focus of this program is the analysis and application of appropriate pharmacotherapy for the treatment of bipolar depression, bipolar mania, cyclothymia, and prevention of relapse. Drug selection, indications, and important safety issues are analyzed in a case study presentation. | 1.50 credits (1.50 pharmacology) | $45.00

This program presents the physiology of anxiety disorders as a foundation for pharmacologic management, key features in differentiating among anxiety disorders, and pharmacologic choices for acute and chronic management. | 1.50 credits (1.50 pharmacology) | $45.00

Understanding the neurobiology of depression and using a pharmacogenomic decision-support tool, clinicians could provide personalized healthcare designed to improve antidepressant therapy outcomes. In this presentation, the evidence, evolution, and current state of antidepressant pharmacogenetic decision support tools are reviewed. A series of considerations for clinicians contemplating the use of these tools is presented in the context of contemporary NP practice. | 1.00 credits (1.00 pharmacology) | $30